This finding denotes that inhibition of RLIP76 protein expression is a common mechanism, along with inhibition of VEGF, by which the anticancer effects of 2HF are mediated in breast cancer cells with diverse ER, PR and HER2 status (Figure 3B and 4B). Here, ESR1 is linked to breast carcinoma.